Who’s Trying to Breathe Life into the Life-Sci Funding Scene in ’12?

Up rounds outpaced down rounds for the first half of 2012, according to a Fenwick & West survey covering venture activity in life sciences companies. Even listed companies in the life sciences space are outpacing broader indices, but early-stage financings have slumped.

North AmericaUS